Best of the Blog is a monthly column highlighting the best of our free online content at www.windhover.com/blog. In April, Windhover's editorial staff posted 23 articles to the site, covering biopharma R&D, business development, regulatory, and commercial news. Highlights included informed musings on comparative effectiveness, regulatory misfires at drug companies, and the ongoing impact of health care reform. Here we've excerpted a few of our favorite blog posts, which are not covered elsewhere in this month's IN VIVO.
That wacky Pulmonary-Allergy Drugs Advisory Committee is at it again! We've noted the remarkable outcome of the review of
